2-phenyl-4-cyclopropyl-pyrimidine derivatives
    4.
    发明授权
    2-phenyl-4-cyclopropyl-pyrimidine derivatives 有权
    2-苯基-4-环丙基 - 嘧啶衍生物

    公开(公告)号:US08466156B2

    公开(公告)日:2013-06-18

    申请号:US12936664

    申请日:2009-04-09

    IPC分类号: C07D403/12 A61K31/506

    CPC分类号: C07D239/28

    摘要: The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

    摘要翻译: 本发明涉及2-苯基-4-环丙基 - 嘧啶衍生物及其作为P2Y12受体拮抗剂用于治疗和/或预防心血管和脑血管疾病的内脏,肝和肾血管的外周血管的用途 或与血小板聚集相关的病症,包括人类和其他哺乳动物的血栓形成。

    Substituted 2-phenyl-pyridine derivatives
    6.
    发明授权
    Substituted 2-phenyl-pyridine derivatives 有权
    取代的2-苯基 - 吡啶衍生物

    公开(公告)号:US08058263B2

    公开(公告)日:2011-11-15

    申请号:US12936661

    申请日:2009-04-09

    IPC分类号: A61K31/675 C07F9/6509

    CPC分类号: C07F9/65583

    摘要: The present invention relates to compounds of formula I wherein R1, R2, R4, R5, Ra, Rb, n, W and Z are as defined in the application, their preparation and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

    摘要翻译: 本发明涉及式I化合物,其中R 1,R 2,R 4,R 5,R a,R b,n,W和Z如申请中所定义,其制备及其作为P2Y12受体拮抗剂在治疗和/或预防中的用途 的外周血管,内脏,肝和肾血管的心血管和脑血管疾病或与血小板聚集相关的病症,包括人和其他哺乳动物的血栓形成。

    2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
    7.
    发明申请
    2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES 有权
    2-苯基-4-环丙基吡啶衍生物

    公开(公告)号:US20110028484A1

    公开(公告)日:2011-02-03

    申请号:US12936664

    申请日:2009-04-09

    CPC分类号: C07D239/28

    摘要: The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

    摘要翻译: 本发明涉及2-苯基-4-环丙基 - 嘧啶衍生物及其作为P2Y12受体拮抗剂用于治疗和/或预防心血管和脑血管疾病的内脏,肝和肾血管的外周血管的用途 或与血小板聚集相关的病症,包括人类和其他哺乳动物的血栓形成。

    2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor
    8.
    发明授权
    2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor 有权
    2-苯基-6-氨基羰基 - 嘧啶衍生物及其作为P2Y12受体的用途

    公开(公告)号:US08044055B2

    公开(公告)日:2011-10-25

    申请号:US12447039

    申请日:2007-10-24

    IPC分类号: C07D239/34 A61K31/506

    摘要: The invention relates to 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention and/or treatment of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals. Formula (I).

    摘要翻译: 本发明涉及2-苯基-6-氨基羰基 - 嘧啶衍生物及其作为P2Y12受体拮抗剂用于治疗和/或预防和/或治疗心脏和血管内脏,肝和肾血管的心血管和 脑血管疾病或与血小板聚集相关的病症,包括人类和其他哺乳动物的血栓形成。 式(I)。

    SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES
    9.
    发明申请
    SUBSTITUTED 2-PHENYL-PYRIDINE DERIVATIVES 有权
    取代的2-苯基 - 吡啶衍生物

    公开(公告)号:US20110046089A1

    公开(公告)日:2011-02-24

    申请号:US12936661

    申请日:2009-04-09

    CPC分类号: C07F9/65583

    摘要: The present invention relates to compounds of formula I wherein R1, R2, R4, R5, Ra, Rb, n, W and Z are as defined in the application, their preparation and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.

    摘要翻译: 本发明涉及式I化合物,其中R 1,R 2,R 4,R 5,R a,R b,n,W和Z如本申请中所定义,其制备及其作为P2Y12受体拮抗剂在治疗和/或预防中的用途 的外周血管,内脏,肝和肾血管的心血管和脑血管疾病或与血小板聚集相关的病症,包括人和其他哺乳动物的血栓形成。